Clinical Trial Update: Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis [Phase 2]

View source ↗

Summary

This update summarizes a Phase 2 trial evaluating rituximab for hepatitis C–associated cryoglobulinemic vasculitis. The study has completed and results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryoglobulinemic Vasculitis
• Hepatitis C

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis C, Vasculitis | Phase 2 | Status: COMPLETED | Results posted: 2012-04-03